Showing results (1-10 of 254) with videos related to
Sort By:
Pageof 26
Bulletin Du Cancer|May 16, 2019
[Stage 1 germ-cell tumour]Sara Faouzi, Siham Ouguellit, Yohann LoriotEuropean Urology Focus|October 18, 2024
Treatments for Patients with Metastatic Castration-resistant Prostate Cancer Who Previously Received Triplet Therapy at the Metastatic Hormone-sensitive StageYohann Loriot, Karim FizaziBulletin Du Cancer|May 31, 2007
[Management of clinical stage I testicular germ cell tumours]Yohann Loriot, Karim FizaziLa Revue Du Praticien|April 26, 2007
[Management of localized germ-cell tumours of the testis]Yohann Loriot, Karim FizaziBulletin Du Cancer|July 5, 2020
[Immunotherapies in non-muscle invasive bladder cancer: immunotherapies and NMIBC]Yohann Loriot, Morgan RouprêtHematology/Oncology Clinics of North America|May 7, 2021
Emerging Targeted Therapy for Bladder CancerConstance Thibault, Yohann LoriotFuture Oncology (London, England)|November 15, 2017
Atezolizumab in urothelial bladder carcinomaZineb Hamilou, Pernelle Lavaud, Yohann LoriotNature Reviews. Clinical Oncology|November 4, 2011
Carcinomas of an unknown primary origin--diagnosis and treatmentChristophe Massard, Yohann Loriot, Karim FizaziWorld Journal of Urology|March 27, 2021
BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?Cedric Lebacle, Yohann Loriot, Jacques IraniThe Urologic Clinics of North America|October 23, 2012
Targeted therapies in metastatic castration-resistant prostate cancer: beyond the androgen receptorYohann Loriot, Amina Zoubeidi, Martin E GleavePageof 26